Annual CFI
-$21.00 K
-$21.00 K-100.00%
31 December 2023
Summary:
Achieve Life Sciences annual cash flow from investing activities is currently -$21.00 thousand, with the most recent change of -$21.00 thousand (-100.00%) on 31 December 2023. During the last 3 years, it has fallen by -$4000.00 (-23.53%). ACHV annual CFI is now -100.06% below its all-time high of $32.43 million, reached on 31 December 2013.ACHV Cash From Investing Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Quarterly CFI
$13.27 M
+$59.84 M+128.50%
30 September 2024
Summary:
Achieve Life Sciences quarterly cash flow from investing activities is currently $13.27 million, with the most recent change of +$59.84 million (+128.50%) on 30 September 2024. Over the past year, it has increased by +$13.29 million (+88573.33%). ACHV quarterly CFI is now -32.04% below its all-time high of $19.53 million, reached on 30 June 2011.ACHV Quarterly CFI Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
TTM CFI
-$33.30 M
+$13.29 M+28.52%
30 September 2024
Summary:
Achieve Life Sciences TTM cash flow from investing activities is currently -$33.30 million, with the most recent change of +$13.29 million (+28.52%) on 30 September 2024. Over the past year, it has dropped by -$33.29 million (-221920.00%). ACHV TTM CFI is now -173.78% below its all-time high of $45.14 million, reached on 30 June 2013.ACHV TTM CFI Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
ACHV Cash From Investing Performance
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
|---|---|---|---|
| 1 y1 year | -100.0% | +10000.0% | -10000.0% |
| 3 y3 years | -23.5% | - | - |
| 5 y5 years | +99.6% | +100.0% | -2607.8% |
ACHV Cash From Investing High & Low
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | TTM vs highTTM vs high | TTM vs lowTTM vs low | |
|---|---|---|---|---|---|---|---|
| 3 y | 3 years | at low | at high | +128.5% | +28.5% | ||
| 5 y | 5 years | -100.4% | +99.6% | at high | +128.5% | -761.3% | +28.5% |
| alltime | all time | -100.1% | +100.0% | -32.0% | +128.5% | -173.8% | +53.8% |
Achieve Life Sciences Cash From Investing History
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Sept 2024 | - | $13.27 M(-128.5%) | -$33.30 M(-28.5%) |
| June 2024 | - | -$46.57 M(>+9900.0%) | -$46.59 M(>+9900.0%) |
| Dec 2023 | -$21.00 K(<-9900.0%) | -$6000.00(-60.0%) | -$21.00 K(+40.0%) |
| Sept 2023 | - | -$15.00 K(<-9900.0%) | -$15.00 K(<-9900.0%) |
| June 2023 | - | $0.00(0.0%) | $0.00(0.0%) |
| Dec 2022 | $0.00(0.0%) | $0.00(0.0%) | $0.00(0.0%) |
| Sept 2022 | - | $0.00(0.0%) | $0.00(-100.0%) |
| Dec 2021 | $0.00(-100.0%) | - | - |
| Dec 2020 | -$17.00 K(-100.3%) | $0.00(-100.0%) | -$17.00 K(-5.6%) |
| Sept 2020 | - | -$3000.00(-75.0%) | -$18.00 K(+20.0%) |
| June 2020 | - | -$12.00 K(+500.0%) | -$15.00 K(-100.6%) |
| Mar 2020 | - | -$2000.00(+100.0%) | $2.34 M(-53.5%) |
| Dec 2019 | $5.04 M(-198.3%) | -$1000.00(<-9900.0%) | $5.04 M(+279.2%) |
| Sept 2019 | - | $0.00(-100.0%) | $1.33 M(-2241.9%) |
| June 2019 | - | $2.35 M(-12.8%) | -$62.00 K(-97.5%) |
| Mar 2019 | - | $2.69 M(-172.5%) | -$2.44 M(-52.3%) |
| Dec 2018 | -$5.13 M(-140.5%) | -$3.71 M(+166.8%) | -$5.13 M(+348.0%) |
| Sept 2018 | - | -$1.39 M(+3761.1%) | -$1.14 M(-109.1%) |
| June 2018 | - | -$36.00 K(-460.0%) | $12.62 M(-0.3%) |
| Mar 2018 | - | $10.00 K(-96.3%) | $12.66 M(+0.1%) |
| Dec 2017 | $12.65 M(>+9900.0%) | $272.00 K(-97.8%) | $12.65 M(+3.8%) |
| Sept 2017 | - | $12.38 M(>+9900.0%) | $12.18 M(+93.1%) |
| Mar 2017 | - | $0.00(-100.0%) | $6.31 M(>+9900.0%) |
| Dec 2016 | $0.00(-100.0%) | -$194.00 K(-102.3%) | $0.00(-100.0%) |
| Sept 2016 | - | $8.48 M(-528.8%) | $2.70 M(-115.8%) |
| June 2016 | - | -$1.98 M(-68.7%) | -$17.09 M(+39.4%) |
| Mar 2016 | - | -$6.31 M(-352.0%) | -$12.26 M(+490.5%) |
| Dec 2015 | -$2.08 M(-138.7%) | $2.50 M(-122.1%) | -$2.08 M(-88.9%) |
| Sept 2015 | - | -$11.31 M(-497.0%) | -$18.70 M(+50.0%) |
| June 2015 | - | $2.85 M(-26.5%) | -$12.47 M(+93.2%) |
| Mar 2015 | - | $3.88 M(-127.5%) | -$6.46 M(-220.3%) |
| Dec 2014 | $5.37 M(-83.5%) | -$14.12 M(+178.2%) | $5.37 M(-81.3%) |
| Sept 2014 | - | -$5.08 M(-157.3%) | $28.67 M(-24.9%) |
| June 2014 | - | $8.86 M(-43.5%) | $38.15 M(+3.4%) |
| Mar 2014 | - | $15.70 M(+71.0%) | $36.89 M(+13.8%) |
| Dec 2013 | $32.43 M(-253.0%) | $9.18 M(+108.3%) | $32.43 M(-17.9%) |
| Sept 2013 | - | $4.41 M(-42.0%) | $39.47 M(-12.5%) |
| June 2013 | - | $7.60 M(-32.3%) | $45.14 M(+456.7%) |
| Mar 2013 | - | $11.24 M(-30.8%) | $8.11 M(-138.3%) |
| Dec 2012 | -$21.19 M(-184.5%) | $16.23 M(+61.1%) | -$21.19 M(+4.9%) |
| Sept 2012 | - | $10.07 M(-134.2%) | -$20.20 M(-31.3%) |
| June 2012 | - | -$29.43 M(+62.9%) | -$29.39 M(-250.2%) |
| Mar 2012 | - | -$18.06 M(-204.9%) | $19.57 M(-21.9%) |
| Dec 2011 | $25.07 M(-142.4%) | $17.21 M(+1842.8%) | $25.07 M(-206.9%) |
| Sept 2011 | - | $886.00 K(-95.5%) | -$23.45 M(-41.9%) |
| June 2011 | - | $19.53 M(-255.5%) | -$40.34 M(-44.0%) |
| Mar 2011 | - | -$12.56 M(-59.9%) | -$72.06 M(+21.9%) |
| Dec 2010 | -$59.13 M(-2752.6%) | -$31.30 M(+95.6%) | -$59.13 M(+111.7%) |
| Sept 2010 | - | -$16.00 M(+31.2%) | -$27.92 M(+117.4%) |
| June 2010 | - | -$12.20 M(-3318.2%) | -$12.84 M(+493.8%) |
| Mar 2010 | - | $379.00 K(-468.0%) | -$2.16 M(-197.0%) |
| Dec 2009 | $2.23 M | -$103.00 K(-88.8%) | $2.23 M(-74.2%) |
| Sept 2009 | - | -$923.00 K(-39.1%) | $8.64 M(+3.6%) |
| June 2009 | - | -$1.52 M(-131.8%) | $8.34 M(+141.8%) |
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Mar 2009 | - | $4.77 M(-24.3%) | $3.45 M(-77.1%) |
| Dec 2008 | $15.09 M(-345.4%) | $6.30 M(-616.7%) | $15.09 M(-19.6%) |
| Sept 2008 | - | -$1.22 M(-81.0%) | $18.77 M(-19.0%) |
| June 2008 | - | -$6.41 M(-139.0%) | $23.19 M(+11.2%) |
| Mar 2008 | - | $16.41 M(+64.2%) | $20.85 M(-439.1%) |
| Dec 2007 | -$6.15 M(-73.3%) | $9.99 M(+212.7%) | -$6.15 M(-71.8%) |
| Sept 2007 | - | $3.20 M(-136.5%) | -$21.83 M(-48.0%) |
| June 2007 | - | -$8.74 M(-17.4%) | -$41.95 M(+25.1%) |
| Mar 2007 | - | -$10.59 M(+86.3%) | -$33.53 M(+45.8%) |
| Dec 2006 | -$23.00 M(-214.5%) | -$5.68 M(-66.4%) | -$23.00 M(+39.3%) |
| Sept 2006 | - | -$16.93 M(+5100.5%) | -$16.52 M(-302.8%) |
| June 2006 | - | -$325.60 K(+453.7%) | $8.14 M(-27.3%) |
| Mar 2006 | - | -$58.80 K(-107.4%) | $11.20 M(-44.3%) |
| Dec 2005 | $20.10 M(-862.1%) | $799.40 K(-89.7%) | $20.10 M(-9.9%) |
| Sept 2005 | - | $7.73 M(+182.6%) | $22.30 M(+35.1%) |
| June 2005 | - | $2.73 M(-69.0%) | $16.50 M(+455.7%) |
| Mar 2005 | - | $8.83 M(+194.7%) | $2.97 M(-212.6%) |
| Dec 2004 | -$2.64 M(-2.2%) | $3.00 M(+55.1%) | -$2.64 M(-71.3%) |
| Sept 2004 | - | $1.93 M(-117.9%) | -$9.19 M(-53.9%) |
| June 2004 | - | -$10.80 M(-434.4%) | -$19.93 M(+330.4%) |
| Mar 2004 | - | $3.23 M(-190.8%) | -$4.63 M(+71.7%) |
| Dec 2003 | -$2.70 M(+11.0%) | -$3.56 M(-59.6%) | -$2.70 M(-166.3%) |
| Sept 2003 | - | -$8.81 M(-295.5%) | $4.07 M(-73.9%) |
| June 2003 | - | $4.50 M(-12.7%) | $15.59 M(+42.8%) |
| Mar 2003 | - | $5.16 M(+61.0%) | $10.91 M(-549.4%) |
| Dec 2002 | -$2.43 M(-69.7%) | $3.21 M(+18.1%) | -$2.43 M(-67.3%) |
| Sept 2002 | - | $2.71 M(-1700.8%) | -$7.43 M(-53.0%) |
| June 2002 | - | -$169.60 K(-97.9%) | -$15.80 M(-8.1%) |
| Mar 2002 | - | -$8.18 M(+354.8%) | -$17.19 M(+114.5%) |
| Dec 2001 | -$8.02 M(-291.2%) | -$1.80 M(-68.2%) | -$8.02 M(+116.1%) |
| Sept 2001 | - | -$5.65 M(+263.0%) | -$3.71 M(-267.6%) |
| June 2001 | - | -$1.56 M(-256.5%) | $2.21 M(+0.8%) |
| Mar 2001 | - | $995.20 K(-60.3%) | $2.20 M(-47.6%) |
| Dec 2000 | $4.19 M(+417.2%) | $2.51 M(+836.6%) | $4.19 M(-335.7%) |
| Sept 2000 | - | $267.70 K(-117.0%) | -$1.78 M(+6.3%) |
| June 2000 | - | -$1.57 M(-152.6%) | -$1.67 M(-155.7%) |
| Mar 2000 | - | $2.99 M(-186.4%) | $3.00 M(+270.3%) |
| Dec 1999 | $810.50 K(-91.1%) | -$3.46 M(-1026.9%) | $810.60 K(-86.9%) |
| Sept 1999 | - | $373.60 K(-87.9%) | $6.17 M(-6.5%) |
| June 1999 | - | $3.10 M(+287.5%) | $6.60 M(-8.3%) |
| Mar 1999 | - | $800.00 K(-57.9%) | $7.20 M(-20.9%) |
| Dec 1998 | $9.10 M(-297.8%) | $1.90 M(+137.5%) | $9.10 M(+116.7%) |
| Sept 1998 | - | $800.00 K(-78.4%) | $4.20 M(-10.6%) |
| June 1998 | - | $3.70 M(+37.0%) | $4.70 M(+1466.7%) |
| Mar 1998 | - | $2.70 M(-190.0%) | $300.00 K(-106.5%) |
| Dec 1997 | -$4.60 M(-22.0%) | -$3.00 M(-330.8%) | -$4.60 M(+24.3%) |
| Sept 1997 | - | $1.30 M(-285.7%) | -$3.70 M(-67.5%) |
| June 1997 | - | -$700.00 K(-68.2%) | -$11.40 M(+0.9%) |
| Mar 1997 | - | -$2.20 M(+4.8%) | -$11.30 M(+91.5%) |
| Dec 1996 | -$5.90 M(-47.3%) | -$2.10 M(-67.2%) | -$5.90 M(+55.3%) |
| Sept 1996 | - | -$6.40 M(+966.7%) | -$3.80 M(-246.2%) |
| June 1996 | - | -$600.00 K(-118.8%) | $2.60 M(-18.8%) |
| Mar 1996 | - | $3.20 M | $3.20 M |
| Dec 1995 | -$11.20 M(>+9900.0%) | - | - |
| Dec 1994 | -$100.00 K | - | - |
FAQ
- What is Achieve Life Sciences annual cash flow from investing activities?
- What is the all time high annual CFI for Achieve Life Sciences?
- What is Achieve Life Sciences annual CFI year-on-year change?
- What is Achieve Life Sciences quarterly cash flow from investing activities?
- What is the all time high quarterly CFI for Achieve Life Sciences?
- What is Achieve Life Sciences quarterly CFI year-on-year change?
- What is Achieve Life Sciences TTM cash flow from investing activities?
- What is the all time high TTM CFI for Achieve Life Sciences?
- What is Achieve Life Sciences TTM CFI year-on-year change?
What is Achieve Life Sciences annual cash flow from investing activities?
The current annual CFI of ACHV is -$21.00 K
What is the all time high annual CFI for Achieve Life Sciences?
Achieve Life Sciences all-time high annual cash flow from investing activities is $32.43 M
What is Achieve Life Sciences annual CFI year-on-year change?
Over the past year, ACHV annual cash flow from investing activities has changed by -$21.00 K (-100.00%)
What is Achieve Life Sciences quarterly cash flow from investing activities?
The current quarterly CFI of ACHV is $13.27 M
What is the all time high quarterly CFI for Achieve Life Sciences?
Achieve Life Sciences all-time high quarterly cash flow from investing activities is $19.53 M
What is Achieve Life Sciences quarterly CFI year-on-year change?
Over the past year, ACHV quarterly cash flow from investing activities has changed by +$13.29 M (+88573.33%)
What is Achieve Life Sciences TTM cash flow from investing activities?
The current TTM CFI of ACHV is -$33.30 M
What is the all time high TTM CFI for Achieve Life Sciences?
Achieve Life Sciences all-time high TTM cash flow from investing activities is $45.14 M
What is Achieve Life Sciences TTM CFI year-on-year change?
Over the past year, ACHV TTM cash flow from investing activities has changed by -$33.29 M (-221920.00%)